Prescription Required
Mounjaro 2.5mg Solution for Injection is a prescription medication designed to help adults with type 2 diabetes manage their blood sugar levels. It contains Tirzepatide, a dual-action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This medication works by enhancing insulin secretion, reducing glucagon production, and slowing gastric emptying, leading to improved blood sugar control. Mounjaro is typically prescribed alongside a healthy diet and regular exercise and is administered once weekly as a subcutaneous injection.
Consuming alcohol may increase the risk of low blood sugar (hypoglycemia) and can worsen side effects like nausea and vomiting. It is advisable to avoid or limit alcohol intake.
Mounjaro may harm the developing fetus. Hence, it must not be used in pregnant women.
It is not known whether Mounjaro passes into breast milk. Talk to your doctor about the risks before using this medication.
Mounjaro may cause dizziness or drowsiness, especially when used with other medications that lower blood sugar levels. If you experience these symptoms, avoid driving or operating heavy machinery.
Use Mounjaro cautiously in patients with severe kidney disease. Consult your doctor before use.
Monitor liver function while on Mounjaro. Patients with severe liver conditions should consult their doctor.
Mounjaro (Tirzepatide) mimics the action of two incretin hormones—GIP and GLP-1—which play a crucial role in regulating blood sugar. It enhances insulin release when blood sugar is high, decreases glucagon secretion (which prevents excess glucose production in the liver), and slows down digestion to reduce spikes in blood sugar after meals. This unique dual-action mechanism helps improve glycemic control in type 2 diabetes patients.
Type 2 diabetes is a chronic condition that affects how the body processes blood sugar (glucose). It occurs when the body becomes resistant to insulin or doesn't produce enough of it. Symptoms include excessive thirst, frequent urination, fatigue, and slow wound healing. Managing diabetes requires a combination of medication, diet, exercise, and lifestyle changes.
Store Mounjaro 2.5mg For Injection 1s in a refrigerator at a temperature between 2°C to 8°C. Do not freeze the medication. Keep it away from direct sunlight and heat to maintain its effectiveness.
Mounjaro 2.5mg Solution for Injection (Tirzepatide) is a breakthrough medication for managing type 2 diabetes. It works through a dual incretin mechanism to improve blood sugar control, suppress appetite, and support weight loss in some patients. This once-weekly injection is an effective addition to a diabetes management plan that includes a healthy diet and exercise.
Content Updated on
Thursday, 27 March, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA